ISIS 2503

DRUG3 trials

Sponsors

University of Alabama at Birmingham, Alliance for Clinical Trials in Oncology

Conditions

Colorectal CancerPancreatic Cancer

Phase 2

Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas

CompletedNCT00006467

Alliance for Clinical Trials in OncologyPancreatic Cancer

Start: 2001-02-28End: 2004-01-31Updated: 2016-07-06

ISIS 2503 in Treating Patients With Advanced Cancer of the Pancreas

CompletedNCT00005594

University of Alabama at BirminghamPancreatic Cancer

Start: 2000-07-31Updated: 2011-01-04

ISIS 2503 in Treating Patients With Metastatic and/or Locally Recurrent Colorectal Cancer

TerminatedNCT00004193

University of Alabama at BirminghamColorectal Cancer

Start: 1999-01-31End: 2000-11-30Target: 25Updated: 2013-04-12